Significant MP calls for RBRC Strains (IMPC_001)  

 

Total number of results: 345

Gene / Allele Procedure Parameter Zygosity Sex Phenotype P-value Graph
Nxn
Nxntm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Nxn
Nxntm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Dbn1
Dbn1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Dbn1
Dbn1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Atp6v0a4
Atp6v0a4tm1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Atp6v0a4
Atp6v0a4tm1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ppp4r2
Ppp4r2tm2b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ppp4r2
Ppp4r2tm2b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Vps11
Vps11em1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Vps11
Vps11em1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Sec24d
Sec24dem1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Sec24d
Sec24dem1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Mat2a
Mat2atm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Mat2a
Mat2atm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Hikeshi
Hikeshiem1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Hikeshi
Hikeshiem1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Unc5c
Unc5cem2(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Unc5c
Unc5cem2(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Edn2
Edn2tm1b(KOMP)Mbp
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Edn2
Edn2tm1b(KOMP)Mbp
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Trpc3
Trpc3tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Trpc3
Trpc3tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Wasf2
Wasf2em1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Wasf2
Wasf2em1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Trf
Trfem1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Trf
Trfem1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Clspn
Clspntm1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Clspn
Clspntm1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Rufy3
Rufy3tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Rufy3
Rufy3tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Sept5
Sept5tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Sept5
Sept5tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Katna1
Katna1em1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Katna1
Katna1em1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Adcyap1r1
Adcyap1r1tm1e.1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Adcyap1r1
Adcyap1r1tm1e.1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Pomc
Pomcem1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Pomc
Pomcem1(IMPC)Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Sec24d
Sec24dem1(IMPC)Rbrc
Gross Pathology and Tissue Collection Stomach heterozygote Male abnormal stomach morphology 0.0
Wasf2
Wasf2em1(IMPC)Rbrc
Gross Pathology and Tissue Collection Stomach heterozygote Female abnormal stomach morphology 0.0
Wasf2
Wasf2em1(IMPC)Rbrc
Gross Pathology and Tissue Collection Stomach heterozygote Male abnormal stomach morphology 0.0
Mpp6
Mpp6em1(IMPC)Rbrc
Gross Pathology and Tissue Collection Stomach homozygote Male abnormal stomach morphology 0.0
Rufy3
Rufy3tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Stomach heterozygote Female abnormal stomach morphology 0.0
Ftl2-ps
Ftl2-psem1(IMPC)Rbrc
Gross Pathology and Tissue Collection Heart homozygote Female abnormal heart morphology 0.0
Ftl2-ps
Ftl2-psem1(IMPC)Rbrc
Gross Pathology and Tissue Collection Heart homozygote Female enlarged heart 0.0
Katna1
Katna1em1(IMPC)Rbrc
Gross Pathology and Tissue Collection Epididymis heterozygote Male abnormal epididymis morphology 0.0
Katna1
Katna1em1(IMPC)Rbrc
Gross Pathology and Tissue Collection Epididymis heterozygote Male enlarged epididymis 0.0
Katna1
Katna1em1(IMPC)Rbrc
Gross Pathology and Tissue Collection Testes heterozygote Male enlarged testis 0.0
D1Pas1
D1Pas1tm1(KOMP)Vlcg
Gross Pathology and Tissue Collection Testes homozygote Male small testis 0.0
Sec24d
Sec24dem1(IMPC)Rbrc
Gross Pathology and Tissue Collection Liver heterozygote Male abnormal liver morphology 0.0
Izumo1r
Izumo1rtm1b(KOMP)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Ppp4r1
Ppp4r1em1(IMPC)Rbrc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
D1Pas1
D1Pas1tm1(KOMP)Vlcg
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Liver homozygote Male small liver 0.0
Cadps2
Cadps2em1(IMPC)Rbrc
Gross Pathology and Tissue Collection Pancreas homozygote Male abnormal pancreas morphology 0.0
Cadps2
Cadps2em1(IMPC)Rbrc
Gross Pathology and Tissue Collection Pancreas homozygote Female abnormal pancreas morphology 0.0
Mpp6
Mpp6em1(IMPC)Rbrc
Gross Pathology and Tissue Collection Spleen homozygote Male abnormal spleen morphology 0.0
Sept5
Sept5tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Spleen heterozygote Female small spleen 0.0
Penk
Penktm1(KOMP)Mbp
Gross Pathology and Tissue Collection Testes homozygote Male absent testes 0.0
Tgm3
Tgm3tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Kidney homozygote Female abnormal kidney morphology 0.0
Ppp4r2
Ppp4r2tm2b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Kidney heterozygote Female abnormal kidney morphology 0.0
Agtr1a
Agtr1aem1(IMPC)Rbrc
Gross Pathology and Tissue Collection Kidney homozygote Male abnormal kidney morphology 0.0
Agtr1a
Agtr1aem1(IMPC)Rbrc
Gross Pathology and Tissue Collection Kidney homozygote Female abnormal kidney morphology 0.0
Cck
Ccktm2b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Kidney homozygote Male abnormal kidney morphology 0.0
Mpp6
Mpp6em1(IMPC)Rbrc
X-ray Tibia length homozygote Female short tibia 0.0
Mpp6
Mpp6em1(IMPC)Rbrc
X-ray Tibia length homozygote Male short tibia 0.0
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Red blood cell distribution width homozygote Female increased red blood cell distribution width 7.510440965595643E-18
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Red blood cell distribution width homozygote Male increased red blood cell distribution width 7.510440965595643E-18
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Female decreased prepulse inhibition 6.625294513565105E-17
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Male decreased prepulse inhibition 6.625294513565105E-17
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Combined SHIRPA and Dysmorphology Skin color - front paws heterozygote Male abnormal skin coloration 6.542612186512264E-16
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - Global homozygote Male decreased prepulse inhibition 2.15619224745397E-15
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - back homozygote Female abnormal coat/hair pigmentation 5.161249150910678E-15
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - head homozygote Female abnormal coat/hair pigmentation 5.161249150910678E-15
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - abdomen homozygote Female abnormal coat/hair pigmentation 5.161249150910678E-15
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Lymphocyte cell count homozygote Female decreased lymphocyte cell number 1.221238889637273E-14
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Lymphocyte cell count homozygote Male decreased lymphocyte cell number 1.221238889637273E-14
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology White blood cell count homozygote Female decreased leukocyte cell number 2.3230190286573776E-14
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology White blood cell count homozygote Male decreased leukocyte cell number 2.3230190286573776E-14
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindpaw - shape homozygote Female abnormal autopod morphology 3.2064260101216657E-13
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Combined SHIRPA and Dysmorphology Skin color - front paws heterozygote Female abnormal skin coloration 3.2064260101216657E-13
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Forelimb digit - size homozygote Female abnormal digit morphology 3.2064260101216657E-13
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb digit - shape homozygote Female abnormal digit morphology 3.2064260101216657E-13
Tfr2
Tfr2em1(IMPC)Rbrc
Hematology Mean corpuscular hemoglobin homozygote Female increased mean corpuscular hemoglobin 7.582423187588172E-13
Tfr2
Tfr2em1(IMPC)Rbrc
Hematology Mean corpuscular hemoglobin homozygote Male increased mean corpuscular hemoglobin 7.582423187588172E-13
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tail - morphology homozygote Female abnormal tail morphology 2.2406269548080893E-12
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - back homozygote Male abnormal coat/hair pigmentation 2.2676689085537882E-12
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - head homozygote Male abnormal coat/hair pigmentation 2.2676689085537882E-12
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - abdomen homozygote Male abnormal coat/hair pigmentation 2.2676689085537882E-12
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 2.4481131098014197E-12
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 2.4481131098014197E-12
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tail - morphology homozygote Male abnormal tail morphology 9.054973784672349E-12
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Hemoglobin homozygote Female decreased hemoglobin content 9.811353118838184E-12
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Hemoglobin homozygote Male decreased hemoglobin content 9.811353118838184E-12
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Hematology Mean corpuscular hemoglobin homozygote Female decreased mean corpuscular hemoglobin 1.6475602132581812E-11
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Hematology Mean corpuscular hemoglobin homozygote Male decreased mean corpuscular hemoglobin 1.6475602132581812E-11
Tfr2
Tfr2em1(IMPC)Rbrc
Hematology Mean cell volume homozygote Female increased mean corpuscular volume 5.578519243765179E-11
Tfr2
Tfr2em1(IMPC)Rbrc
Hematology Mean cell volume homozygote Male increased mean corpuscular volume 5.578519243765179E-11
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean cell hemoglobin concentration homozygote Female decreased mean corpuscular hemoglobin concentration 7.05958694280362E-11
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean cell hemoglobin concentration homozygote Male decreased mean corpuscular hemoglobin concentration 7.05958694280362E-11
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean corpuscular hemoglobin homozygote Female decreased mean corpuscular hemoglobin 7.119752010176228E-11
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean corpuscular hemoglobin homozygote Male decreased mean corpuscular hemoglobin 7.119752010176228E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tail - length homozygote Female abnormal tail length 7.984000960359339E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb digit - size homozygote Female abnormal digit morphology 7.984000960359339E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tail - length homozygote Male abnormal tail length 8.064161144405446E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindpaw - shape homozygote Male abnormal autopod morphology 8.064161144405446E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Forelimb digit - size homozygote Male abnormal digit morphology 8.064161144405446E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb digit - shape homozygote Male abnormal digit morphology 8.064161144405446E-11
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 4.2591366544719733E-10
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 4.2591366544719733E-10
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female increased startle reflex 5.128389934938582E-10
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male increased startle reflex 5.128389934938582E-10
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Glycosilated hemoglobin A1c (HbA1c) homozygote Female increased glycosylated hemoglobin level 5.522567403382084E-10
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Glycosilated hemoglobin A1c (HbA1c) homozygote Male increased glycosylated hemoglobin level 5.522567403382084E-10
Atp13a2
Atp13a2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 1.0796296079362833E-9
Atp13a2
Atp13a2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 1.0796296079362833E-9
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Female short tibia 1.4577485885070018E-9
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Male short tibia 1.4577485885070018E-9
Tfr2
Tfr2em1(IMPC)Rbrc
Clinical Chemistry Iron homozygote Female increased circulating iron level 2.250609698606354E-9
Tfr2
Tfr2em1(IMPC)Rbrc
Clinical Chemistry Iron homozygote Male increased circulating iron level 2.250609698606354E-9
Nlgn3
Nlgn3em1(IMPC)Rbrc
Open Field Whole arena resting time homozygote Female hyperactivity 4.6743275916583116E-9
Atp13a2
Atp13a2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 6.374258454400206E-9
Atp13a2
Atp13a2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 6.374258454400206E-9
Uts2
Uts2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 6.662132623347361E-9
Uts2
Uts2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 6.662132623347361E-9
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Hematology Red blood cell distribution width homozygote Female increased red blood cell distribution width 9.130205036456118E-9
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Hematology Red blood cell distribution width homozygote Male increased red blood cell distribution width 9.130205036456118E-9
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
X-ray Brachydactyly homozygote Female brachydactyly 1.1809110134208822E-8
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
X-ray Brachydactyly homozygote Male brachydactyly 1.1809110134208822E-8
Sec24d
Sec24dem1(IMPC)Rbrc
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Male impaired glucose tolerance 2.1139204164910552E-8
Uts2
Uts2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 4.226250993610847E-8
Uts2
Uts2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 4.226250993610847E-8
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Total bilirubin homozygote Female increased circulating bilirubin level 4.5014367344720085E-8
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Total bilirubin homozygote Male increased circulating bilirubin level 4.5014367344720085E-8
Tfr2
Tfr2em1(IMPC)Rbrc
Hematology Red blood cell count homozygote Female decreased erythrocyte cell number 4.719055013424622E-8
Tfr2
Tfr2em1(IMPC)Rbrc
Hematology Red blood cell count homozygote Male decreased erythrocyte cell number 4.719055013424622E-8
Gal
Galtm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 4.962296884514217E-8
Gal
Galtm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 4.962296884514217E-8
Sept5
Sept5tm1b(EUCOMM)Hmgu
Hematology Platelet count heterozygote Female thrombocytopenia 5.204031339189896E-8
Sept5
Sept5tm1b(EUCOMM)Hmgu
Hematology Platelet count heterozygote Male thrombocytopenia 5.204031339189896E-8
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Male decreased prepulse inhibition 5.3546873601817424E-8
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) CV heterozygote Female cardiovascular system phenotype 1.2260748860626336E-7
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) CV heterozygote Male cardiovascular system phenotype 1.2260748860626336E-7
Sept5
Sept5tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV heterozygote Female cardiovascular system phenotype 1.5217207760542806E-7
Sept5
Sept5tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV heterozygote Male cardiovascular system phenotype 1.5217207760542806E-7
Trpc5
Trpc5tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc hemizygote Male prolonged QT interval 1.6924259682582488E-7
Sept5
Sept5tm1b(EUCOMM)Hmgu
X-ray Tibia length heterozygote Female short tibia 1.7638556926158344E-7
Sept5
Sept5tm1b(EUCOMM)Hmgu
X-ray Tibia length heterozygote Male short tibia 1.7638556926158344E-7
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
X-ray Pelvis homozygote Male abnormal pelvic girdle bone morphology 2.31983406706604E-7
Trf
Trfem1(IMPC)Rbrc
Clinical Chemistry Iron heterozygote Female decreased circulating iron level 2.510511194486753E-7
Trf
Trfem1(IMPC)Rbrc
Clinical Chemistry Iron heterozygote Male decreased circulating iron level 2.510511194486753E-7
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Hematocrit homozygote Female decreased hematocrit 2.772520986127347E-7
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Hematocrit homozygote Male decreased hematocrit 2.772520986127347E-7
Trpc5
Trpc5tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST hemizygote Male prolonged ST segment 3.3906951557582943E-7
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Neutrophil differential count homozygote Female increased neutrophil cell number 3.405133099931845E-7
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Neutrophil differential count homozygote Male increased neutrophil cell number 3.405133099931845E-7
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI4 homozygote Female decreased prepulse inhibition 3.5058667435805546E-7
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI4 homozygote Male decreased prepulse inhibition 3.5058667435805546E-7
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Indirect Calorimetry Respiratory Exchange Ratio homozygote Female decreased respiratory quotient 3.5697621569852345E-7
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Indirect Calorimetry Respiratory Exchange Ratio homozygote Male decreased respiratory quotient 3.5697621569852345E-7
Gal
Galtm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 4.1197077393917425E-7
Gal
Galtm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 4.1197077393917425E-7
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 4.7091020860534627E-7
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 4.7091020860534627E-7
Nin
Nintm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV homozygote Female cardiovascular system phenotype 4.950609877596435E-7
Nin
Nintm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV homozygote Male cardiovascular system phenotype 4.950609877596435E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Indirect Calorimetry Respiratory Exchange Ratio homozygote Female decreased respiratory quotient 6.275930104493455E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Indirect Calorimetry Respiratory Exchange Ratio homozygote Male decreased respiratory quotient 6.275930104493455E-7
Cadps2
Cadps2em1(IMPC)Rbrc
Hematology Eosinophil differential count homozygote Female decreased eosinophil cell number 6.862010764052684E-7
Cadps2
Cadps2em1(IMPC)Rbrc
Hematology Eosinophil differential count homozygote Male decreased eosinophil cell number 6.862010764052684E-7
Nxn
Nxntm1b(EUCOMM)Wtsi
X-ray Tibia length heterozygote Female short tibia 7.566728186247929E-7
Nxn
Nxntm1b(EUCOMM)Wtsi
X-ray Tibia length heterozygote Male short tibia 7.566728186247929E-7
Mpp6
Mpp6em1(IMPC)Rbrc
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 9.068526196642779E-7
Mpp6
Mpp6em1(IMPC)Rbrc
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 9.068526196642779E-7
Rnf10
Rnf10tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 9.296348366660823E-7
Rnf10
Rnf10tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 9.296348366660823E-7
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Alpha-amylase homozygote Female decreased circulating amylase level 1.0576991371635813E-6
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Alpha-amylase homozygote Male decreased circulating amylase level 1.0576991371635813E-6
Pdyn
Pdynem1(IMPC)Rbrc
Electrocardiogram (ECG) QRS homozygote Female shortened QRS complex duration 1.0966176660076599E-6
Pdyn
Pdynem1(IMPC)Rbrc
Electrocardiogram (ECG) QRS homozygote Male shortened QRS complex duration 1.0966176660076599E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Female abnormal sensory capabilities/reflexes/nociception 1.1304105100862216E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Male abnormal sensory capabilities/reflexes/nociception 1.1304105100862216E-6
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Clinical Chemistry HDL-cholesterol homozygote Male decreased circulating HDL cholesterol level 1.3832703871230478E-6
Sst
Ssttm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Female improved glucose tolerance 1.6161112625923124E-6
Sst
Ssttm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Male improved glucose tolerance 1.6161112625923124E-6
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 1.64382174716593E-6
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 1.64382174716593E-6
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 1.6500268884556135E-6
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 1.6500268884556135E-6
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Gait homozygote Female abnormal gait 1.6600070011918433E-6
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Combined SHIRPA and Dysmorphology Skin color - back paws heterozygote Female abnormal skin coloration 1.6600070011918433E-6
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb digit - size homozygote Male abnormal digit morphology 1.6699669913577964E-6
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 12kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 1.9000000293090125E-6
Nin
Nintm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 12kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 1.9000000293090125E-6
Nin
Nintm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 18kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 1.9000000293090125E-6
Nin
Nintm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 24kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 1.9000000293090125E-6
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 2.1183559510973282E-6
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 2.1183559510973282E-6
Sst
Ssttm1b(KOMP)Wtsi
Clinical Chemistry Albumin homozygote Male increased circulating serum albumin level 2.221260729129426E-6
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean cell volume homozygote Female decreased mean corpuscular volume 2.6907571282208664E-6
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean cell volume homozygote Male decreased mean corpuscular volume 2.6907571282208664E-6
Nin
Nintm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 30kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 3.000000106112566E-6
Ikzf5
Ikzf5tm1(KOMP)Wtsi
Auditory Brain Stem Response 30kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 3.000000106112566E-6
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV homozygote Female cardiovascular system phenotype 3.0373671506822575E-6
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV homozygote Male cardiovascular system phenotype 3.0373671506822575E-6
Mpp6
Mpp6em1(IMPC)Rbrc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 3.124077693428262E-6
Mpp6
Mpp6em1(IMPC)Rbrc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 3.124077693428262E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female increased bone mineral content 3.279106749687344E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male increased bone mineral content 3.279106749687344E-6
Sst
Ssttm1b(KOMP)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Female decreased circulating alkaline phosphatase level 3.461516371316975E-6
Sst
Ssttm1b(KOMP)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Male decreased circulating alkaline phosphatase level 3.461516371316975E-6
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 4.1421540117880795E-6
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 4.1421540117880795E-6
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response Click-evoked ABR threshold homozygote increased or absent threshold for auditory brainstem response 4.200000148557592E-6
Nin
Nintm1b(EUCOMM)Hmgu
Auditory Brain Stem Response Click-evoked ABR threshold homozygote increased or absent threshold for auditory brainstem response 4.200000148557592E-6
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Lymphocyte differential count homozygote Female decreased lymphocyte cell number 6.094693617342273E-6
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Lymphocyte differential count homozygote Male decreased lymphocyte cell number 6.094693617342273E-6
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
X-ray Pelvis homozygote Female abnormal pelvic girdle bone morphology 7.549432211817475E-6
Rnf10
Rnf10tm1b(KOMP)Wtsi
Hematology Hemoglobin homozygote Female decreased hemoglobin content 8.804623575997539E-6
Rnf10
Rnf10tm1b(KOMP)Wtsi
Hematology Hemoglobin homozygote Male decreased hemoglobin content 8.804623575997539E-6
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 9.216807484335732E-6
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 9.216807484335732E-6
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 1.013600831356598E-5
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 1.013600831356598E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Distance travelled - total homozygote Female hyperactivity 1.0264468073728494E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Distance travelled - total homozygote Male hyperactivity 1.0264468073728494E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Whole arena average speed homozygote Female hyperactivity 1.0264673619531095E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Whole arena average speed homozygote Male hyperactivity 1.0264673619531095E-5
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Female decreased total body fat amount 1.1048252417822368E-5
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 1.1048252417822368E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 1.129298016167013E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 1.129298016167013E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 1.1964496479777154E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 1.1964496479777154E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Heart Weight Heart weight homozygote Female decreased heart weight 1.2220844837429468E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Heart Weight Heart weight homozygote Male decreased heart weight 1.2220844837429468E-5
Sst
Ssttm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 1.2396695638017263E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Hematology Mean corpuscular hemoglobin homozygote Female decreased mean corpuscular hemoglobin 1.311438245465979E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Hematology Mean corpuscular hemoglobin homozygote Male decreased mean corpuscular hemoglobin 1.311438245465979E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Clinical Chemistry Alkaline phosphatase homozygote Female increased circulating alkaline phosphatase level 1.329940278083086E-5
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 6kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 1.3799999578623101E-5
Vps39
Vps39tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 1.4247354556573555E-5
Vps39
Vps39tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 1.4247354556573555E-5
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
X-ray Tibia length homozygote Female short tibia 1.4463027582678478E-5
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
X-ray Tibia length homozygote Male short tibia 1.4463027582678478E-5
Vps39
Vps39tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 1.7390604625688866E-5
Vps39
Vps39tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 1.7390604625688866E-5
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 1.744939618220087E-5
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 1.744939618220087E-5
Shank2
Shank2em2(IMPC)Rbrc
Combined SHIRPA and Dysmorphology Limb grasp homozygote Female limb grasping 1.7953540009330027E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 1.7958776879822835E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 1.7958776879822835E-5
Tfr2
Tfr2em1(IMPC)Rbrc
Hematology Mean cell hemoglobin concentration homozygote Female increased mean corpuscular hemoglobin concentration 1.8371645637671463E-5
Tfr2
Tfr2em1(IMPC)Rbrc
Hematology Mean cell hemoglobin concentration homozygote Male increased mean corpuscular hemoglobin concentration 1.8371645637671463E-5
Gypc
Gypcem1(IMPC)Rbrc
Clinical Chemistry Glycosilated hemoglobin A1c (HbA1c) homozygote Female decreased glycosylated hemoglobin level 1.8515627743909135E-5
Gypc
Gypcem1(IMPC)Rbrc
Clinical Chemistry Glycosilated hemoglobin A1c (HbA1c) homozygote Male decreased glycosylated hemoglobin level 1.8515627743909135E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Female improved glucose tolerance 1.8793216440826654E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Male improved glucose tolerance 1.8793216440826654E-5
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI2 homozygote Male decreased prepulse inhibition 1.8950839148601517E-5
Galp
Galptm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Locomotor activity homozygote Male hyperactivity 1.9159579096594825E-5
Galp
Galptm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Locomotor activity homozygote Female hypoactivity 1.9159579096594825E-5
Nlgn3
Nlgn3em1(IMPC)Rbrc
Open Field Center average speed hemizygote Male abnormal behavior 1.9829929442494176E-5
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Monocyte differential count homozygote Female increased monocyte cell number 2.8946420570719056E-5
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Monocyte differential count homozygote Male increased monocyte cell number 2.8946420570719056E-5
Sec24d
Sec24dem1(IMPC)Rbrc
Clinical Chemistry Alkaline phosphatase heterozygote Female increased circulating alkaline phosphatase level 3.157522951369174E-5
Sec24d
Sec24dem1(IMPC)Rbrc
Clinical Chemistry Alkaline phosphatase heterozygote Male increased circulating alkaline phosphatase level 3.157522951369174E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 3.17933336191345E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 3.17933336191345E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Hematology Eosinophil differential count homozygote Female decreased eosinophil cell number 3.188427581335418E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Hematology Eosinophil differential count homozygote Male decreased eosinophil cell number 3.188427581335418E-5
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV heterozygote Female cardiovascular system phenotype 3.3576376154087484E-5
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV heterozygote Male cardiovascular system phenotype 3.3576376154087484E-5
Trf
Trfem1(IMPC)Rbrc
Hematology Hemoglobin heterozygote Female increased hemoglobin content 3.4069678804371506E-5
Trf
Trfem1(IMPC)Rbrc
Hematology Hemoglobin heterozygote Male increased hemoglobin content 3.4069678804371506E-5
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 3.5687982745002955E-5
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 3.5687982745002955E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Indirect Calorimetry Total food intake homozygote Female decreased food intake 3.6295077734394E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Indirect Calorimetry Total food intake homozygote Male decreased food intake 3.6295077734394E-5
Atp6v1g2
Atp6v1g2em1(IMPC)Rbrc
Open Field Center average speed homozygote Female abnormal behavior 3.7905894714640453E-5
Atp6v1g2
Atp6v1g2em1(IMPC)Rbrc
Open Field Center average speed homozygote Male abnormal behavior 3.7905894714640453E-5
Dbn1
Dbn1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 3.829441629932262E-5
Dbn1
Dbn1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 3.829441629932262E-5
Cadps2
Cadps2em1(IMPC)Rbrc
Hematology Eosinophil cell count homozygote Female decreased eosinophil cell number 4.03948943130672E-5
Cadps2
Cadps2em1(IMPC)Rbrc
Hematology Eosinophil cell count homozygote Male decreased eosinophil cell number 4.03948943130672E-5
Nlgn3
Nlgn3em1(IMPC)Rbrc
Open Field Center resting time homozygote Female abnormal behavior 4.2014875361928716E-5
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 4.431087654666044E-5
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 4.431087654666044E-5
Prkab1
Prkab1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 4.463582445168868E-5
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 4.794545020558871E-5
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 4.794545020558871E-5
Sst
Ssttm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 5.217844227445312E-5
Dbn1
Dbn1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 5.281758421915583E-5
Dbn1
Dbn1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 5.281758421915583E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Female increased circulating alkaline phosphatase level 5.3024032240500674E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Male increased circulating alkaline phosphatase level 5.3024032240500674E-5
Penk
Penktm1(KOMP)Mbp
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 5.742668508901261E-5
Penk
Penktm1(KOMP)Mbp
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 5.742668508901261E-5
Trf
Trfem1(IMPC)Rbrc
Hematology Mean corpuscular hemoglobin heterozygote Female increased mean corpuscular hemoglobin 5.794159369543195E-5
Trf
Trfem1(IMPC)Rbrc
Hematology Mean corpuscular hemoglobin heterozygote Male increased mean corpuscular hemoglobin 5.794159369543195E-5
Prkab1
Prkab1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 5.8830686612054706E-5
Rln3
Rln3tm1(KOMP)Mbp
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 6.164482329040766E-5
Rln3
Rln3tm1(KOMP)Mbp
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male decreased bone mineral content 6.164482329040766E-5
Stx7
Stx7em1(IMPC)Rbrc
Hematology Large Unstained Cell (LUC) count homozygote Female decreased large unstained cell number 6.652593583567068E-5
Stx7
Stx7em1(IMPC)Rbrc
Hematology Large Unstained Cell (LUC) count homozygote Male decreased large unstained cell number 6.652593583567068E-5
Pomc
Pomcem1(IMPC)Rbrc
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Male impaired glucose tolerance 6.825447053415701E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Female decreased total body fat amount 6.829239282524213E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 6.829239282524213E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
X-ray Tibia length homozygote Female short tibia 6.947375368326902E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
X-ray Tibia length homozygote Male short tibia 6.947375368326902E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Indirect Calorimetry Total water intake homozygote Female decreased fluid intake 7.316759001696482E-5
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 7.625445869052783E-5
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 7.625445869052783E-5
Ppp4r1
Ppp4r1em1(IMPC)Rbrc
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 7.68006284488365E-5
Ppp4r1
Ppp4r1em1(IMPC)Rbrc
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 7.68006284488365E-5
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 7.706175529165193E-5
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 7.706175529165193E-5
Nlgn3
Nlgn3em1(IMPC)Rbrc
Open Field Center distance travelled hemizygote Male abnormal behavior 7.81382477725856E-5
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 7.94960287748836E-5
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 7.94960287748836E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Open Field Percentage center time heterozygote Female abnormal behavior 8.041026012506336E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Open Field Percentage center time heterozygote Male abnormal behavior 8.041026012506336E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Open Field Periphery permanence time heterozygote Female abnormal behavior 8.041067485464737E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Open Field Periphery permanence time heterozygote Male abnormal behavior 8.041067485464737E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Open Field Center permanence time heterozygote Female abnormal behavior 8.041067485464737E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Open Field Center permanence time heterozygote Male abnormal behavior 8.041067485464737E-5
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 8.570379577577114E-5
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 8.570379577577114E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Clinical Chemistry LDL-cholesterol homozygote Female decreased circulating LDL cholesterol level 8.620385779067874E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Clinical Chemistry LDL-cholesterol homozygote Male decreased circulating LDL cholesterol level 8.620385779067874E-5
Nin
Nintm1b(EUCOMM)Hmgu
Open Field Number of center entries homozygote Female abnormal behavior 8.823833923088387E-5
Nin
Nintm1b(EUCOMM)Hmgu
Open Field Number of center entries homozygote Male abnormal behavior 8.823833923088387E-5
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Large Unstained Cell (LUC) count homozygote Female decreased large unstained cell number 8.870206511346623E-5
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Large Unstained Cell (LUC) count homozygote Male decreased large unstained cell number 8.870206511346623E-5